UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Multinational drugmakers hypocritical in cancer, orphan drug biz’
by Nam Doo-hyun
2018-05-23 15:06
Obesity treatment Saxenda supplied to 10 general hospitals
by Nam Doo-hyun
2018-05-23 11:13
Refusals of off-label drugs spiked last year
by Nam Doo-hyun
2018-05-17 15:23
How China’s scrapping of tariffs will affect Korea’s drug exports?
by Nam Doo-hyun
2018-05-16 12:14
Merck’s Erbitux extends RSA status
by Nam Doo-hyun
2018-05-15 14:31
라인
Biotech shares weaken on KONEX, too
by Nam Doo-hyun
2018-05-15 14:02
‘Breast cancer drug Faslodex needs insurance coverage’
by Nam Doo-hyun
2018-05-11 11:31
Samsung BioLogics shares recover despite window dressing controversy
by Nam Doo-hyun
2018-05-10 11:08
Va-Q-Tec to up investment in Korean biopharmaceuticals
by Nam Doo-hyun
2018-05-09 11:54
Pharma, biotech shares tank amid Samsung BioLogics debacle
by Nam Doo-hyun
2018-05-08 11:20
라인
How much cheaper will Keytruda be as first-line treatment?
by Nam Doo-hyun
2018-05-03 14:51
Will US oncology conference boost Korean biotech shares?
by Nam Doo-hyun
2018-04-27 16:29
Guerbet Korea under fire for exploiting monopoly drug
by Nam Doo-hyun
2018-04-26 15:37
GC Pharma has most patents among large drug suppliers
by Nam Doo-hyun
2018-04-26 11:08
Pharma shares on the rise since early this year
by Nam Doo-hyun
2018-04-25 13:56
라인
3 Korean pipelines listed in 537 new drug candidates in US
by Nam Doo-hyun
2018-04-24 11:21
Insulin Toujeo beats Tresiba in patient number
by Nam Doo-hyun
2018-04-23 16:01
Korean units of GSK, Pfizer send highest dividends to parent firms
by Nam Doo-hyun
2018-04-20 14:48
Biotech stocks could be overpriced: analysts
by Nam Doo-hyun
2018-04-19 13:34
AstraZeneca up, Novartis down in Q1 outpatient prescriptions
by Nam Doo-hyun
2018-04-18 14:58
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top